Vertex Pharmaceuticals Inc. buy Truist Financial Co.
Start price
31.01.24
/
50%
€400.85
Target price
31.01.25
€470.15
Performance (%)
5.08%
Price
24.05.24
€421.20
Summary
This prediction is currently active. The BUY prediction by Truist_Financial_Co_ shows slight gains of 5.08%. This prediction currently runs until 31.01.25. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Vertex Pharmaceuticals Inc. | 2.845% | 2.845% |
iShares Core DAX® | -0.205% | 2.949% |
iShares Nasdaq 100 | 1.613% | 5.877% |
iShares Nikkei 225® | -0.740% | -1.256% |
iShares S&P 500 | 0.267% | 3.240% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at Truist Financial Co. from $456.00 to $508.00. They now have a "buy" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€332.85
04.10.23
04.10.23
€434.43
04.10.24
04.10.24
26.54%
24.05.24
24.05.24